The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation

Lipids in Health and Disease

Volumn 7, Issue , 2008, Pages

  Magee, Peter ^a   Pearson, Stephen ^a   Allen, Jeremy ^a  

^a UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; PROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE NECROSIS; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; MOUSE; MUSCLE CELL; NECROSIS;

MURINAE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; DRUG ANTAGONISM; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; MICE; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCLE, SKELETAL; NECROSIS; PROTECTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49249134734     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-7-24     Document Type: Article

References (46)

1. Inflammatory processes in muscle injury and repair. JG Tidball, Am J Physiol Regul Integr Comp Physiol 2005 288 2 R345 53 15637171
2. Establishment of a human cell line secreting neuron-specific enolase from a primitive neuroectodermal tumor of the retroperitoneal cavity. J Nakashima Y Horiguchi M Ueno K Nakamura M Tachibana J Hata H Tazaki, Jpn J Cancer Res 1995 86 12 1172 1178 8636006
3. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. G Vreugdenhil B Lowenberg HG Van Eijk AJ Swaak, European journal of clinical investigation 1992 22 7 488 493 1516597 10.1111/j.1365-2362.1992.tb01495.x
4. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. R Roubenoff RA Roubenoff LM Ward SM Holland DB Hellmann, J Rheumatol 1992 19 10 1505 1510 1464859
5. Tumor necrosis factor, other cytokines and disease. KJ Tracey A Cerami, Annual review of cell biology 1993 9 317 343 8280464 10.1146/annurev.cb.09. 110193.001533
6. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. RC Langen AM Schols MC Kelders JL Van Der Velden EF Wouters YM Janssen-Heininger, Am J Physiol Cell Physiol 2002 283 3 C714 21 12176728
7. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. SE Chen B Jin YP Li, American journal of physiology 2007 292 5 C1660 71 17151142 10.1152/ajpcell.00486.2006
8. The acute metabolic effects of tumor necrosis factor administration in humans. RS Warren HF Starnes Jr. JL Gabrilove HF Oettgen MF Brennan, Arch Surg 1987 122 12 1396 1400 3689116
9. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Y Fong LL Moldawer M Marano H Wei A Barber K Manogue KJ Tracey G Kuo DA Fischman A Cerami, The American journal of physiology 1989 256 3 Pt 2 R659 65 2784290
10. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. EA Flores BR Bistrian JJ Pomposelli CA Dinarello GL Blackburn NW Istfan, The Journal of clinical investigation 1989 83 5 1614 1622 2785120 10.1172/JCI114059
11. The role of cytokines in cancer cachexia. LL Moldawer MA Rogy SF Lowry, Jpen 1992 16 6 Suppl 43S 49S 1287223
12. Through thick and thin: wasting, obesity, and TNF alpha. BM Spiegelman GS Hotamisligil, Cell 1993 73 4 625 627 8500160 10.1016/0092-8674(93)90243-J
13. Tumor necrosis factor inhibits human myogenesis in vitro. SC Miller H Ito HM Blau FM Torti, Mol Cell Biol 1988 8 6 2295 2301 3405207
14. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. K Szalay Z Razga E Duda, Eur J Cell Biol 1997 74 4 391 398 9438136
15. Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression. SQ Ji S Neustrom GM Willis ME Spurlock, J Interferon Cytokine Res 1998 18 10 879 888 9809624
16. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. RC Langen AM Schols MC Kelders EF Wouters YM Janssen-Heininger, Faseb J 2001 15 7 1169 1180 11344085 10.1096/fj.00-0463
17. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. L Tolosa M Morla A Iglesias X Busquets J Llado G Olmos, Cellular signalling 2005 17 11 1333 1342 16125053 10.1016/j.cellsig.2005.02.001
18. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. KA Meadows JM Holly CE Stewart, Journal of cellular physiology 2000 183 3 330 337 10797307 10.1002/(SICI)1097- 4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N
19. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways. CE Stewart PV Newcomb JM Holly, Journal of cellular physiology 2004 198 2 237 247 14603526 10.1002/jcp.10387
20. Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. B Alvarez LS Quinn S Busquets FJ Lopez-Soriano JM Argiles, Eur Cytokine Netw 2001 12 3 399 410 11566620
21. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999 354 9177 447 455 10465168 10.1016/S0140-6736(99)07072-5
22. Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications. T Babcock WS Helton NJ Espat, Nutrition 2000 16 11-12 1116 1118 10.1016/S0899-9007(00)00392-0 11118844
23. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model. MJ Tisdale JK Dhesi, Cancer Res 1990 50 16 5022 5026 2379167
24. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. AS Whitehouse HJ Smith JL Drake MJ Tisdale, Cancer Res 2001 61 9 3604 3609 11325828
25. Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: modulation by eicosapentaenoic acid. HJ Smith MJ Lorite MJ Tisdale, Cancer Res 1999 59 21 5507 5513 10554027
26. Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid. HJ Smith MJ Tisdale, Apoptosis 2003 8 2 161 169 12766476 10.1023/A:1022970609579
27. Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor. E Kishida M Tajiri Y Masuzawa, Biochim Biophys Acta 2006 1761 4 454 462 16698313
28. Tumor necrosis factor alpha signaling in skeletal muscle: effects of age and caloric restriction. AJ Dirks C Leeuwenburgh, The Journal of nutritional biochemistry 2006 17 8 501 508 16517142 10.1016/j.jnutbio.2005.11.002
29. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. MD Layne SR Farmer, Experimental cell research 1999 249 1 177 187 10328964 10.1006/excr.1999.4465
30. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. RC Langen JL Van Der Velden AM Schols MC Kelders EF Wouters YM Janssen-Heininger, Faseb J 2004 18 2 227 237 14769817 10.1096/fj.03-0251com
31. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. M Yano E Kishida M Iwasaki S Kojo Y Masuzawa, The Journal of nutrition 2000 130 5 1095 1101 10801904
32. Novel action of n-3 polyunsaturated fatty acids: inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases. N Moghaddami J Irvine X Gao PK Grover M Costabile CS Hii A Ferrante, Arthritis and rheumatism 2007 56 3 799 808 10.1002/art.22432 17328054
33. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. CJ Lo KC Chiu M Fu R Lo S Helton, The Journal of surgical research 1999 86 1 103 107 10452875 10.1006/jsre.1999.5684
34. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. Y Zhao S Joshi-Barve S Barve LH Chen, Journal of the American College of Nutrition 2004 23 1 71 78 14963056
35. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. CJ Lo KC Chiu M Fu R Lo S Helton, The Journal of surgical research 1999 82 2 216 221 10090832 10.1006/jsre.1998.5524
36. Controlling inflammation: a fat chance? RJ Flower M Perretti, The Journal of experimental medicine 2005 201 5 671 674 15753201 10.1084/jem.20050222
37. Phospolipase A2 and apoptosis. MM Taketo M Sonoshita, Biochim Biophys Acta 2002 1585 2-3 72 76 12531539
38. Death receptor activation complexes: it takes two to activate TNF receptor 1. MS Sheikh Y Huang, Cell Cycle 2003 2 6 550 552 14504472
39. The biochemistry of n-3 polyunsaturated fatty acids. DB Jump, The Journal of biological chemistry 2002 277 11 8755 8758 11748246 10.1074/jbc.R100062200
40. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. C Weigert K Brodbeck H Staiger C Kausch F Machicao HU Haring ED Schleicher, The Journal of biological chemistry 2004 279 23 23942 23952 15028733 10.1074/jbc.M312692200
41. Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil. S Sethi, Redox Rep 2002 7 6 369 378 12625944 10.1179/135100002125001144
42. Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. Z Gao Q He B Peng PJ Chiao J Ye, The Journal of biological chemistry 2006 281 7 4540 4547 16371367 10.1074/jbc.M507784200
43. Altered PPARgamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. J Singh NK Verma SM Kansagra BN Kate CS Dey, Molecular and cellular biochemistry 2007 294 1-2 163 171 10.1007/s11010-006-9256-x 16838108
44. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. C Chambrier JP Bastard J Rieusset E Chevillotte D Bonnefont-Rousselot P Therond B Hainque JP Riou M Laville H Vidal, Obesity research 2002 10 6 518 525 12055328 10.1038/oby.2002.70
45. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. D Yaffe O Saxel, Nature 1977 270 5639 725 727 563524 10.1038/270725a0
46. The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. CU Niesler KH Myburgh F Moore, Experimental physiology 2007 92 1 207 217 16945942 10.1113/expphysiol.2006.034736